Harbour Investments’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,725
Closed -$562K 3397
2024
Q1
$562K Sell
1,725
-680
-28% -$167K 0.02% 554
2023
Q4
$458K Buy
2,405
+313
+15% +$59.2K 0.02% 561
2023
Q3
$417K Buy
2,092
+1,059
+103% +$250K 0.02% 542
2023
Q2
$295K Sell
1,033
-267
-21% -$74.1K 0.01% 659
2023
Q1
$282K Buy
1,300
+41
+3% +$7.99K 0.02% 642
2022
Q4
$259K Sell
1,259
-206
-14% -$52.1K 0.02% 650
2022
Q3
$280K Hold
1,465
0.02% 577
2022
Q2
$280K Buy
+1,465
New +$259K 0.02% 577
2021
Q4
$191K Buy
1,073
+52
+5% +$10.3K 0.01% 735
2021
Q3
$210K Hold
1,021
0.01% 999
2021
Q2
$194K Buy
1,021
+13
+1% +$2.13K 0.01% 1058
2021
Q1
$131K Buy
+1,008
New +$121K ﹤0.01% 1170

Other funds holding SWAV

Harbour Investments's SWAV Position: Q2 2024 in Review

Harbour Investments sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,725 shares — an estimated $562K sold.

Harbour Investments first reported a position in SWAV in Q1 2021 and held it in 12 quarters. The position peaked at $562K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Harbour Investments reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Harbour Investments sold 1,725 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $562K.
  • Harbour Investments first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Harbour Investments's Shockwave Medical, Inc. Common Stock position peaked at $562K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Harbour Investments's 13F filing for Q2 2024, filed 26 Jul 2024.